Lisanti Capital Growth LLC reduced its stake in Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI – Free Report ) by 44.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,510 shares of the biopharmaceutical company's stock after selling 51,024 shares during the period. Lisanti Capital Growth LLC owned approximately 0.07% of Intra-Cellular Therapies worth $3,439,000 as of its most recent SEC filing. Other hedge funds have also bought and sold shares of the company.

https://www.dailypolitical.com/2023/08/05/lisanti-capital-growth-llc-lowers-position-in-intra-cellular-therapies-inc-nasdaqitci.html

#dailypolitical